Transgene SA
TRGNF
$0.70
-$0.89-55.98%
| Weiss Ratings | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.81 | |||
| Price History | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -55.97% | |||
| 60-Day Total Return | -55.97% | |||
| 90-Day Total Return | -55.97% | |||
| Year to Date Total Return | -55.97% | |||
| 1-Year Total Return | -56.79% | |||
| 2-Year Total Return | -65.85% | |||
| 3-Year Total Return | -75.27% | |||
| 5-Year Total Return | -42.15% | |||
| 52-Week High % Change | -55.97% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.59 | |||
| 52-Week Low Price | $0.70 | |||
| 52-Week Low Price (Date) | Apr 01, 2025 | |||
| 52-Week High Price (Date) | Jun 06, 2024 | |||
| Valuation | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 93.65M | |||
| Enterprise Value | 86.72M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.25 | |||
| Earnings Per Share Growth | -31.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 10.07 | |||
| Price/Book (Q) | -107.69 | |||
| Enterprise Value/Revenue (TTM) | 12.44 | |||
| Price | $0.70 | |||
| Enterprise Value/EBITDA (TTM) | -2.73 | |||
| Enterprise Value/EBIT | -2.59 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 100.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 33 3 88 27 91 00 | |||
| Address | -- | |||
| Website | www.transgene.fr | |||
| Country | France | |||
| Year Founded | 1979 | |||
| Profitability | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -480.03% | |||
| Profit Margin | -352.69% | |||
| Management Effectiveness | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -38.86% | |||
| Return on Equity | -- | |||
| Income Statement | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 30.30K | |||
| Total Revenue (TTM) | 7.02M | |||
| Revenue Per Share | $0.07 | |||
| Gross Profit (TTM) | -24.82M | |||
| EBITDA (TTM) | -32.02M | |||
| EBIT (TTM) | -33.72M | |||
| Net Income (TTM) | -24.78M | |||
| Net Income Avl. to Common (TTM) | -24.78M | |||
| Total Revenue Growth (Q YOY) | -30.31% | |||
| Earnings Growth (Q YOY) | -2.51% | |||
| EPS Diluted (TTM) | -0.25 | |||
| EPS Diluted Growth (Q YOY) | -0.92% | |||
| Balance Sheet | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 16.41M | |||
| Cash Per Share (Q) | $0.16 | |||
| Total Current Assets (Q) | 20.49M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -660.00K | |||
| Current Ratio (Q) | 1.571 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 54.38M | |||
| Total Current Liabilities (Q) | 13.04M | |||
| Total Debt (Q) | 39.41M | |||
| Total Liabilities (Q) | 55.04M | |||
| Total Common Equity (Q) | -660.00K | |||
| Cash Flow | TRGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 16.49M | |||
| Cash from Financing (TTM) | 34.09M | |||
| Net Change in Cash (TTM) | 12.56M | |||
| Levered Free Cash Flow (TTM) | 6.19M | |||
| Cash from Operations (TTM) | -38.45M | |||
